(Q33487661)

English

Intraperitoneal 5-fluoro-2'-deoxyuridine (FUDR) and (S)-leucovorin for disease predominantly confined to the peritoneal cavity: a pharmacokinetic and toxicity study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Intraperitoneal 5-fluoro-2'-deoxyuridine (FUDR) and (S)-leucovorin for disease predominantly confined to the peritoneal cavity: a pharmacokinetic and toxicity study (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

author name string

V K Israel

1

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

C Jiang

2

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

A Tulpule

4

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

S Jeffers

5

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

L Leichman

6

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

C P Morrow

7

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

L Roman

8

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

C G Leichman

9

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

K K Chan

10

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

publication date

1 January 1995

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Cancer Chemotherapy and Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

37

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

1-2

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

32-38

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Phase I and pharmacologic evaluation of intraperitoneal 5-fluoro-2'-deoxyuridine

1 reference

https://pubmed.ncbi.nlm.nih.gov/7497594

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospective randomized trial of intravenous v intraperitoneal 5-FU in patients with advanced primary colon or rectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/7497594

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intraperitoneal 5-fluoro-2'-deoxyuridine with escalating doses of leucovorin: pharmacology and clinical tolerance

1 reference

https://pubmed.ncbi.nlm.nih.gov/7497594

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I clinical and pharmacologic study of intraperitoneal cisplatin and fluorouracil in patients with advanced intraabdominal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/7497594

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intraperitoneal therapy for ovarian cancer: analysis of fluid distribution by computerized tomography

1 reference

https://pubmed.ncbi.nlm.nih.gov/7497594

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intraperitoneal cisplatin-based chemotherapy for ovarian carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/7497594

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Folinic acid augmentation of the effects of fluoropyrimidines on murine and human leukemic cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/7497594

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term results of a cisplatin-containing combination chemotherapy regimen for the treatment of advanced ovarian carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/7497594

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Salicylazosulfapyridine-induced agranulocytosis in a patient with ulcerative colitis, successfully treated with granulocyte colony-stimulating factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/7497594

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I and pharmacologic studies of intraperitoneal leucovorin and 5-fluorouracil in patients with advanced cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/7497594

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacology of intraperitoneal infusion 5-fluorouracil and mitomycin-C

1 reference

https://pubmed.ncbi.nlm.nih.gov/7497594

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase III trial. Gastrointestinal Tumor Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/7497594

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical pharmacological studies of concurrent infusion of 5-fluorouracil and thymidine in treatment of colorectal carcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/7497594

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Portal levels and hepatic clearance of 5-fluorouracil after intraperitoneal administration in humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/7497594

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum, urine and peritoneal fluid levels of 5-FU following intraperitoneal administration

1 reference

https://pubmed.ncbi.nlm.nih.gov/7497594

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relapse-preventing effect and safety of sulfasalazine and olsalazine in patients with ulcerative colitis in remission: a prospective, double-blind, randomized multicenter study. The Ulcerative Colitis Multicenter Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/7497594

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of 5-FU administered Ip to patients with refractory ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/7497594

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S002800050364

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33487661&oldid=2143355621"